Literature DB >> 17487891

Severe interference between retinal angiography and automated four-color flow cytometry analysis of blood mononuclear cells.

Philippe Bürgisser1, Jean Vaudaux, Pierre-Alexandre Bart.   

Abstract

BACKGROUND: Retinal angiography has become a widely used diagnostic tool. It requires the intravenous administration of the fluorescent dyes fluorescein and indocyanin green. We recently received blood taken 8 h after retinal angiography, without our knowing it. We describe the failure of an automated flow cytometry system in the enumeration of lymphocyte subpopulations in this sample.
METHODS: Cell enumeration was achieved by the use of the lyse-no wash MultiTEST procedure (Becton-Dickinson) together with the FACSCalibur cytometer. Absolute cell counts were obtained using TruCount beads. Data were analyzed automatically by the MultiSET and manually with the CellQuest softwares.
RESULTS: The dot plots obtained with this sample looked quite abnormal. All monuclear cells stained brightly in the FITC channel irrespective of anti-CD3-FITC conjugate binding. This resulted in a major undercompensation for the increased spillover of the fluorescein emission into the PE-channel. PE-labeled cell and TruCount bead events coalesced. The MultiSET software failed to draw proper gatings and proved useless. Alternative manual gatings could partially rescue the analysis.
CONCLUSIONS: Clinicians and cytometrists should be aware that, because of dye entry or binding, blood mononuclear cells collected shortly after retinal angiography are not suitable even for common cytometry applications. Copyright 2007 International Society for Analytical Cytology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487891     DOI: 10.1002/cyto.a.20414

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  7 in total

1.  CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.

Authors:  Mads Krüger Falk; Amardeep Singh; Carsten Faber; Mogens Holst Nissen; Thomas Hviid; Torben Lykke Sørensen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

2.  Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.

Authors:  Amardeep Singh; Yousif Subhi; Marie Krogh Nielsen; Mads Krüger Falk; Sara Maj Hyldig Matzen; Finn Sellebjerg; Torben Lykke Sørensen
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

3.  Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile.

Authors:  Thomas Bjerregaard; Marie Krogh Nielsen; Christopher Rue Molbech; Yousif Subhi; Torben Lykke Sørensen
Journal:  BMJ Open Ophthalmol       Date:  2019-07-18

4.  Fluorescein angiography leads to increased fluorescence of blood cells and may hamper routine haematology analysis of ophthalmology patients.

Authors:  Evianne L de Groot; Albert Huisman; Wouter W van Solinge; Jeannette Ossewaarde-van Norel; Saskia Haitjema
Journal:  Int J Lab Hematol       Date:  2021-10-27       Impact factor: 3.450

5.  The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study.

Authors:  Amardeep Singh; Mads Krüger Falk; Yousif Subhi; Torben Lykke Sørensen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

6.  Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study.

Authors:  Mads Krüger Falk; Amardeep Singh; Carsten Faber; Mogens Holst Nissen; Thomas Hviid; Torben Lykke Sørensen
Journal:  BMC Ophthalmol       Date:  2014-02-27       Impact factor: 2.209

7.  Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration.

Authors:  Marie Krogh Nielsen; Sven Magnus Hector; Kelly Allen; Yousif Subhi; Torben Lykke Sørensen
Journal:  Immun Ageing       Date:  2017-07-27       Impact factor: 6.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.